Mercury Laboratories Limited has submitted a regulatory filing to the BSE Limited Listing Compliance Department regarding an upcoming board meeting. The meeting of the Board of Directors is scheduled to be held on Saturday, July 25, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026 (Q1 FY2027).
The filing is made pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR).
Additionally, the company has implemented a closed trading window period in compliance with its Code of Conduct for Prevention of Insider Trading. The trading restriction period began on July 1, 2026 and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026.
The communication was digitally signed by Krishna Dhruv Shah, who holds the position of Company Secretary & Compliance Officer for Mercury Laboratories Limited, on July 16, 2026 at 17:31:09 IST.